Design and synthesis of extended quinoxaline derivatives and their charge transport properties

Junwei Yang, Haoyun Zhu, Yuli Huang, Wei Huang and Weizhi Wang*
The State Key Laboratory of Molecular Engineering of Polymers, Collaborative Innovation Center of Polymers and Polymer Composite Materials, Department of Macromolecular Science, Fudan University, Shanghai 200433, China. E-mail: weizhiwang@fudan.edu.cn; Tel: +86-021-65643836

Received 11th September 2016 , Accepted 6th October 2016

First published on 7th October 2016


Abstract

A scalable and convenient strategy is described to synthesize extended conjugation quinoxaline derivatives from phenylene-ethynylene arrays. By tuning the solvent, the compounds display bright emission solvatochromism. Furthermore, the fabricated FET devices possess good performance characteristics, with mobilities of 0.47 cm2 V−1 s−1 and 0.99 cm2 V−1 s−1. The mobilities are higher than those of corresponding to the alkyl substituted compounds, which can be proven by grazing incidence X-ray diffraction (GIXRD) measurement.


Hetero- and polycyclic aromatic hydrocarbons (hetero-PAHs) have attracted increasing attention for their design, synthesis and application because of some fascinating features, such as high stability, low energy absorption, and high charge carrier mobility.1 Among the large N-substituted heterocycles that are pervasive in natural products, biologically active agents2 and part structures in functional π-systems,3 quinoxalines are extraordinarily attractive.4 Several derivatives have been proven to possess in vitro antiparasitic5 and anti-tumor activities,6 and some have been used as 5-HT3 receptors7 or kinase inhibitors.8 In addition, quinoxalines have also been applied as building blocks for the development of semiconducting materials,9 fluorescent probes,10 sensors,11 anion receptors12 and cavitands.13 In general, the reaction features condensation of 1,2-diamines with diketones to afford quinoxaline derivatives.14 Recently, a one-pot strategy has been proposed to construct quinoxaline oligomers using expensive metal catalysts, followed by tedious isolation procedures.15

Due to this consideration, a series of conjugation extended quinoxalines are prepared using a simple catalyst and facile isolation. Dicarbonyl derivatives, as intermediate products, have been obtained without much effort, and are useful building blocks capable of undergoing various chemical transformations.16 Different π-conjugated phenylene-ethynylene arrays were used as starting compounds to control the sequence of the conjugation chain of final products. The insertion of electron-withdrawing quinoxalines on the phenylene-ethynylene backbone influences the electronic structures and various properties of the resulting compounds. Alkyl chains (n-butyl) are introduced to the compounds to improve solubility.

The oxidation of alkynes was catalyzed efficiently by PdCl2 to afford intermediate products 5–8, in which DMSO acted as a powerful oxidant (Scheme 1). The condensation reaction of compounds 5–8 and 1,2-phenylenediamine successfully afforded quinoxaline derivatives 9–12 in good yields, after plain filtration of 5–8. Brunet products were avoided and white solids finally precipitated after these two separate steps. In our experimentation, the stepwise process was the key to obtain pure products in high yields, which was verified by 1H NMR and 13C NMR (Fig. S1–S40). With the increase in the π-conjugated skeleton, 11–12 are poorly soluble in acetic acid, leading to their nearly complete precipitation from the reaction mixture. A needle-like single crystal of 10b was obtained by recrystallization from acetic acid. The X-ray analysis was conducted to establish the structure shown in Fig. 1 and Table S1.


image file: c6ra22677a-s1.tif
Scheme 1 Synthetic procedures for compounds 5–12.

image file: c6ra22677a-f1.tif
Fig. 1 The ORTEP drawing of 10b.

The ultraviolet/visible (UV/vis) absorption and photoluminescence (PL) spectra of 9–12 in chloroform are shown in Fig. S41 and S42, and the data are compared in Table 1. The extended structural unit affects the position of the absorption and emission bands across the series from 9 to 12, although the red-shift is not prominent. However, the electron-donating effect of the n-butyl substituent results in a red-shift of the longer wavelength absorption band to ca. 390 nm, which changes the electron cloud density of the adjacent benzene ring. In chloroform, compound 12b emits deep blue photoluminescence with an emission maximum at 418 nm. However, the emission changes to bright green in acetone solution. Depending on the identity of the solvent, its polarity results in quite positive and significant changes to the emission wavelength, ranging from 432 to 518 nm (Fig. 2a). This pronounced positive emission solvatochromism is observable with naked eyes, where the color changes from blue (toluene) to yellow-green (DMSO) (Fig. 2a). More polarizable solvent served to stabilize the excited state more than the ground state, which lessens the energy gap.17 We also determined the photophysical properties of 12a in the same solvents and observed a similar bathochromic trend, exhibiting PL emission maxima in the range from 480 to 525 nm (Fig. 2b).

Table 1 Photophysical properties of compounds 9a–12a and 9b–12b
Sample UVa (λmax/nm) PLa (λmax/nm) ΦFa,b (%)
a Absorption maximum in dilute CHCl3 solutions.b Quantum yield estimated with quinine sulfate (ΦF = 54% in 0.1 M H2SO4).
9a 345 413 5.23
10a 358 416 10.35
11a 359 421 31.32
12a 359 425 54.37
9b 390 416 5.32
10b 394 417 11.24
11b 395 417 35.11
12b 396 418 62.33



image file: c6ra22677a-f2.tif
Fig. 2 Solvent-dependent emission spectra of (a) 12b and (b) 12a. Inset: optical photographs of corresponding compounds in different solvents.

The introduction of an electron-donating or electron-accepting group directly affects the HOMO and LUMO levels of the compounds. The cyclic voltammetry curves of quinoxaline derivatives 9–12 show no reversible peaks arising from the oxidation potential, which is ascribed to the electron-deficient pyrazine ring containing two sp2-type centers (Fig. S43).18 In the anodic scan, the onset of oxidation for 9a–12a occurrs at 1.06, 0.88, 0.75 and 0.70 V, which corresponds to HOMO values of −5.81, −5.63, −5.50 and −5.45 eV, respectively (Table 2). The oxidation potential values of alkylated oligomers follow the order 9b > 10b > 11b > 12b; this is the same trend that is evident for compounds 9a–12a. The extended conjugation length slightly raises the HOMO level and consequently reduces the band gap of the oligomers. The energy band gaps of 9a–12a are calculated to be 3.28, 3.18, 3.15 and 3.12 eV, as determined from the onset wavelength of their UV absorptions. The HOMO–LUMO energy gaps show good correlation with their UV data and the molecular extended conjugation chain.

Table 2 Electrochemical properties of compounds 9a–12a and 9b–12ba
Sample Eoxonset (V) HOMO (eV) λonset (nm) ΔEg (eV) LUMO (eV)
a Abbreviations: Eoxonset is the onset potential for oxidation. HOMO is calculated by the equation: HOMO = −e(Eoxonset − 0.0468 V) − 4.8 eV. λonset is the onset wavelength of UV absorptions. LUMO = ΔEg + HOMO.
9a 1.06 −5.81 378 3.28 −2.53
10a 0.88 −5.63 389 3.18 −2.45
11a 0.75 −5.50 394 3.15 −2.35
12a 0.70 −5.45 397 3.12 −2.33
9b 0.96 −5.71 390 3.18 −2.53
10b 0.86 −5.61 395 3.14 −2.47
11b 0.73 −5.48 396 3.13 −2.35
12b 0.69 −5.44 398 3.12 −2.32


The transfer integral and reorganization energy, which are believed to be important for the mobility of semiconductors, are both based on the arrangement of the organic molecules.19 To further inspect and compare the molecular packing characteristics of quinoxaline derivatives with the extended skeleton, two-dimensional grazing incidence X-ray diffraction (2D-GIXRD) measurements were performed. As for oligomer 12a, the clear (100) reflection arch appears along the qz direction with a value of 11.2 nm−1 (Fig. 3a). Furthermore, a clear arch shape of the (010) diffraction peak in the in-plane direction appears at qxy = 18.01 nm−1, which corresponds to the π–π stacking distance of 3.49 Å. Evidently, 12a tends to pack more orderly and tightly than 12b in neat films, which may be due to the steric hindrance caused by the alkyl chains. The prominent (010) arch of compound 12b appears at qxy = 17.50 nm−1, with π–π distance of 3.59 Å (Fig. 3b). Compared with the variation in π–π stacking, the alkyl substituent is of larger influence for the spacing in the out-of-plane direction. The intense reflections of the (100) plane along the qz (out-of-plane) axis and a relatively weak (010) plane along the qxy (in-plane) axis of 12b films can be observed from Fig. 3b, which implies that 12b molecules would prefer to have an edge-on structure.20 The ordered edge-on structure of organic molecules prefers to be formed in high performance FETs, which allows the molecules to arrange along the direction of the conducting channel and then get an efficient charge transport.19 In addition, the decreased length of the conjugated chain makes some differences. Compared to 12a, the out-of-plane spacing of 11a increased to 5.66 Å and the π–π stacking distance also rose to 3.50 Å (Fig. S44).


image file: c6ra22677a-f3.tif
Fig. 3 The 2D-GIXRD pattern of (a) 12a and (b) 12b.

The higher HOMO energy level suggests that 12 might have great potential for use in field-effect transistors (FETs) as p-type materials.21 Furthermore, N-heteroatoms provide a new method of tuning the intrinsic molecular electronic properties and improving stability, which have been extensively studied areas for organic thin film transistors.22 Quinoxaline derivatives 11a–12a and 11b–12b have high thermal stabilities, which are beneficial for the processing of electrical devices (Fig. S45). We evaluated the charge transport properties of the oligomers 11a–12a and 11b–12b by fabricating field-effect transistors in the “top-contact top-gate” geometry. To this end, FETs using the quinoxaline derivatives were fabricated using ion gels23 to efficiently diminish the heat generated at work and to endow low voltage operation.24 Moreover, top-gated quinoxaline derivative transistors prepared using ion gel gate dielectrics have been rarely reported. The representative transfer curve (IDVG) of the FET with 11a is displayed in Fig. 4a and that of the 12a is shown in Fig. 4c. The best results of 11a and 11b devices exhibit mobilities up to 0.47 cm2 V−1 s−1 and 0.44 cm2 V−1 s−1, respectively, with on/off ratios up to 103 (Fig. S46). Significant increases of the mobilities are also observed in the 12a, 12b based devices of 0.99 cm2 V−1 s−1 and 0.88 cm2 V−1 s−1, respectively, as evaluated from the saturation regime (Fig. S47). In addition, the output characteristics (IDVD) of the aluminum-gated quinoxaline derivative based FETs at five different gate voltages (VG) are shown in Fig. 4b and d, affirming the clear p-channel characteristics. The structure–property relationship has been verified by a range of analyses, particularly using 2D-GIXRD. The substantial structural change has an enormous influence on the packing of the neighboring molecules, which in turn affects the specific properties. The extended conjugation chain and the closer structures did have a great influence on the conductive properties according to the above comparisons. The mobility of 12 is among the best results ever reported for N-heteroatoms.25


image file: c6ra22677a-f4.tif
Fig. 4 (a) Transfer and (b) output characteristics of the 11a devices (W = L = 1000 μm) at a drain source voltage (VDS) of 2.5 V. (c) Transfer and (d) output characteristics of the 12a based FETs.

Conclusions

In summary, a series of extended conjugation quinoxaline oligomers 9–12 have been successfully synthesized by a convenient and efficient route with a simple isolation procedure. The compounds 12a and 12b display positive emission solvatochromism, as revealed by detailed optical studies. The performance of 11a and 12a based FET devices is comparable, showing mobilities of 0.47 cm2 V−1 s−1 for 11a and 0.99 cm2 V−1 s−1 for 12a. Furthermore, the FETs fabricated with 11b and 12b are also measured, and mobilities are lower than those of 11a and 12a. The employment of 2D-GIXRD provides a direct explanation for the difference in FET performance between 12a and 12b, in which the alkyl chain weakens the molecular packing.

Acknowledgements

This work was financially supported by the National Natural Science Foundation of China (21274027 and 20974022) and the Innovation Program of Shanghai Municipal Education Commission (15ZZ002). The FETs were fabricated and characterized in Fudan Nanofabrication Laboratory. The synchrotron-based 2D-GIXRD measurement was supported by Shanghai Synchrotron Radiation Facility (15ssrf00474).

Notes and references

  1. (a) C. Wang, J. Zhang, G. Long, N. Aratani, H. Yamada, Y. Zhao and Q. Zhang, Angew. Chem., Int. Ed., 2015, 54, 6292–6296 CrossRef CAS PubMed; (b) C. Dou, S. Saito, K. Matsuo, I. Hisaki and S. Yamaguchi, Angew. Chem., Int. Ed., 2012, 51, 12206–12210 CrossRef CAS PubMed.
  2. M. Ishikura, T. Abe, T. Choshi and S. Hibino, Nat. Prod. Rep., 2013, 30, 694–752 RSC.
  3. (a) T. Meyer, D. Ogermann, A. Pankrath, K. Kleinermanns and T. J. J. Müller, J. Org. Chem., 2012, 77, 3704–3715 CrossRef CAS PubMed; (b) W. Chen, K. Tian, X. Song, Z. Zhang, K. Ye, G. Yu and Y. Wang, Org. Lett., 2015, 17, 6146–6149 CrossRef CAS PubMed.
  4. (a) T.-C. Chou, K.-C. Lin, M. Kon-no, C.-C. Lee and T. Shinmyozu, Org. Lett., 2011, 13, 4588–4591 CrossRef CAS PubMed; (b) J. A. Pereira, A. M. Pessoa, M. N. Cordeiro, R. Fernandes, C. Prudencio, J. P. Noronha and M. Vieira, Eur. J. Med. Chem., 2015, 97, 664–672 CrossRef CAS PubMed.
  5. J. Guillon, E. Mouray, S. Moreau, C. Mullie, I. Forfar, V. Desplat, S. Belisle-Fabre, N. Pinaud, F. Ravanello, A. Le-Naour, J.-M. Leger, G. Gosmann, C. Jarry, G. Deleris, P. Sonnet and P. Grellier, Eur. J. Med. Chem., 2011, 46, 2310–2326 CrossRef CAS PubMed.
  6. (a) Q. Weng, D. Wang, P. Guo, L. Fang, Y. Hu, Q. He and B. Yang, Eur. J. Pharmacol., 2008, 581, 262–269 CrossRef CAS PubMed; (b) D. Patrizia, M. Annamaria, B. Paola, M. Alessandra, D. Gaetano, C. Girolamo, D. Francesco, S. Alessia, V. Daniela, B. Giuseppe and V. Giampietro, J. Med. Chem., 2008, 51, 2387–2399 CrossRef PubMed.
  7. S. Butini, R. Budriesi, M. Hamon, E. Morelli, S. Gemma, M. Brindisi, G. Borrelli, E. Novellino, I. Fiorini, P. Ioan, A. Chiarini, A. Cagnotto, T. Mennini, C. Fracasso, S. Caccia and G. Campiani, J. Med. Chem., 2009, 52, 6946–6950 CrossRef CAS PubMed.
  8. C. Srinivas, C. N. S. S. P. Kumar, V. J. Rao and S. Palaniappan, J. Mol. Catal. A: Chem., 2007, 265, 227–230 CrossRef CAS.
  9. (a) E. Wang, L. Hou, Z. Wang, S. Hellström, F. Zhang, O. Inganäs and M. R. Andersson, Adv. Mater., 2010, 22, 5240–5244 CrossRef CAS PubMed; (b) Y. Wu, Z. Yin, J. Xiao, Y. Liu, F. Wei, K. J. Tan, C. Kloc, L. Huang, Q. Yan, F. Hu, H. Zhang and Q. Zhang, ACS Appl. Mater. Interfaces, 2012, 4, 1883–1886 CrossRef CAS PubMed; (c) D.-W. Chang, H.-J. Lee, J.-H. Kim, S.-Y. Park, S.-M. Park, L. Dai and J.-B. Baek, Org. Lett., 2011, 13, 3880–3883 CrossRef CAS PubMed; (d) W. Chen, Q. Zhang, T. Salima, S. A. Ekahana, X. Wan, T. C. Sumd, Y. M. Lama, A. H. H. Cheng, Y. Chen and Q. Zhang, Tetrahedron, 2014, 70, 6217–6221 CrossRef CAS.
  10. H. Liu, T. Duan, Z. Zhang, C. Xie and C. Ma, Org. Lett., 2015, 17, 2932–2935 CrossRef CAS PubMed.
  11. (a) G. Li, Y. Wu, J. Gao, J. Li, Y. Zhao and Q. Zhang, Chem.–Asian J., 2013, 8, 1574–1578 CrossRef CAS PubMed; (b) P. Gu, Z. Wang and Q. Zhang, J. Mater. Chem. B, 2016 10.1039/c6tb02052f.
  12. (a) T. Kazunobu, O. Ryusuke and M. Tomohiro, Chem. Commun., 2002, 212 Search PubMed; (b) Y. Qu, J. Hua and H. Tian, Org. Lett., 2010, 12, 3320–3323 CrossRef CAS PubMed.
  13. B. D. Lindner, Y. Zhang, S. Hofle, N. Berger, C. Teusch, M. Jesper, K. I. Hardcastle, X. Qian, U. Lemmer, A. Colsmann, U. H. F. Bunz and M. Hamburger, J. Mater. Chem. C, 2013, 1, 5718–5724 RSC.
  14. (a) D. Zhang, Y. Yang, M. Gao, W. Shu, L. Wu, Y. Zhu and A. Wu, Tetrahedron, 2013, 69, 1849–1856 CrossRef CAS; (b) Y. Xu and X. Wan, Tetrahedron Lett., 2013, 54, 642–645 CrossRef CAS.
  15. C. Mousset, O. Provot, A. Hamze, J. Bignon, J.-D. Brion and M. Alami, Tetrahedron, 2008, 64, 4287–4294 CrossRef CAS.
  16. (a) S. K. Singh, V. Saibaba, V. Ravikumar, S. V. Rudrawar, P. Daga, C. S. Rao, V. Akhila, P. Hegde and Y. K. Rao, Bioorg. Med. Chem., 2004, 12, 1881–1893 CrossRef CAS PubMed; (b) X. Deng and N. S. Mani, Org. Lett., 2006, 8, 269–292 CrossRef CAS PubMed.
  17. S. Nigam and S. Rutan, Appl. Spectrosc., 2001, 55, 362A–370A CrossRef CAS.
  18. H.-J. Son, W.-S. Han, K.-R. Wee, D.-H. Yoo, J.-H. Lee, S.-N. Kwon, J. Ko and S. O. Kang, Org. Lett., 2008, 10, 5401–5404 CrossRef CAS PubMed.
  19. C. Wang, H. Dong, W. Hu, Y. Liu and D. Zhu, Chem. Rev., 2012, 112, 2208–2267 CrossRef CAS PubMed.
  20. Y. Qu, Q. Su, S. Li, G. Lu, X. Zhou, J. Zhang, Z. Chen and X. Yang, ACS Macro Lett., 2012, 1, 1274–1278 CrossRef CAS.
  21. (a) Q. Miao, Adv. Mater., 2014, 26, 5541–5549 CrossRef CAS PubMed; (b) J. Li and Q. Zhang, ACS Appl. Mater. Interfaces, 2015, 7, 28049–28062 CrossRef PubMed; (c) C. Wang, P. Gu, B. Hu and Q. Zhang, J. Mater. Chem. C, 2015, 3, 10055–10065 RSC.
  22. S. Yang, B. Shan, X. Xu and Q. Miao, Chemistry, 2016, 22, 6637–6642 CrossRef CAS PubMed.
  23. (a) H. Okamoto, R. Eguchi, S. Hamao, H. Goto, K. Gotoh, Y. Sakai, M. Izumi, Y. Takaguchi, S. Gohda and Y. Kubozono, Sci. Rep., 2014, 4, 5330 CAS; (b) T. Fujimoto and K. Awaga, Phys. Chem. Chem. Phys., 2013, 15, 8983–9006 RSC.
  24. (a) B. J. Kim, H. Jang, S. K. Lee, B. H. Hong, J. H. Ahn and J. H. Cho, Nano Lett., 2010, 10, 3464–3466 CrossRef CAS PubMed; (b) C. Zhang, Y. Zang, E. Gann, C. R. McNeill, X. Zhu, C.-A. Di and D. Zhu, J. Am. Chem. Soc., 2014, 136, 16176–16184 CrossRef CAS PubMed.
  25. (a) U. H. Bunz, J. U. Engelhart, B. D. Lindner and M. Schaffroth, Angew. Chem., Int. Ed., 2013, 52, 3810–3821 CrossRef CAS PubMed; (b) Q. Miao, Synlett, 2012, 23, 326–336 CrossRef CAS.

Footnote

Electronic supplementary information (ESI) available: Experimental section including materials, measurements and characterizations, devices fabrication and characterization; mass spectra, NMR data for new compounds, UV, PL and cyclic voltammetry spectra of compounds and CCDC reference number of 10b. CCDC 1499076. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c6ra22677a

This journal is © The Royal Society of Chemistry 2016
Click here to see how this site uses Cookies. View our privacy policy here.